Clinical trial

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis

NCT02944799

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Alendronate Normalized identity: alendronateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Calcium Normalized identity: calciumView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vitamin D Normalized identity: vitamin DView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Osteoporosisverified · MONDO: osteoporosis

Interventions

PlaceboDRUG

AlendronateDRUG · verified · RxNorm: alendronate

CalciumDRUG · verified · RxNorm: calcium

Vitamin DDRUG · verified · RxNorm: vitamin D

Sponsors & collaborators

University of Aarhuslead sponsor

Mapped research locations

AarhusDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02944799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.